We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01933802
Recruitment Status : Completed
First Posted : September 2, 2013
Last Update Posted : March 19, 2018
Information provided by (Responsible Party):
Tisch Multiple Sclerosis Research Center of New York